DGAP-News: Prothena Announces Pricing of Public Offering of 5,910,000 Ordinary Shares
(firmenpresse) - Prothena Corporation
03.10.2013 12:00
---------------------------------------------------------------------------
DUBLIN, Ireland, 2013-10-03 12:00 CEST (GLOBE NEWSWIRE) --
Prothena Corporation plc. (Nasdaq:PRTA), a clinical stage biotechnology company
focused on the discovery and development of novel antibodies for the potential
treatment of a broad range of diseases, announced that it has priced an
underwritten public offering of 5,910,000 of its ordinary shares at a price of
$22.00 per ordinary share, before underwriting discounts and commissions. Of
these ordinary shares, Prothena is offering 3,500,000 ordinary shares and
Janssen Pharmaceutical, a wholly owned subsidiary of Johnson&Johnson, as
selling shareholder, is offering 2,410,000 ordinary shares. In addition, the
underwriters have been granted a 30-day option to purchase up to an additional
886,500 ordinary shares. If the option is exercised in full, Prothena will
issue and sell an additional 677,079 ordinary shares and Janssen Pharmaceutical
will sell an additional 209,421 ordinary shares, which represents all of
Janssen's shareholdings in Prothena.
Net proceeds to Prothena from the ordinary shares to be sold by Prothena in the
offering are expected to be $70.8 million, after deducting the underwriting
discount and estimated offering expenses, but excluding any exercise of the
underwriters' option to purchase additional ordinary shares. Prothena will not
receive any proceeds from the sale of ordinary shares by Janssen
Pharmaceutical. The offering is expected to close on or about October 8, 2013,
subject to customary closing conditions.
BofA Merrill Lynch, Credit Suisse and RBC Capital Markets are acting as joint
book-running managers and Wedbush PacGrow Life Sciences and Roth Capital
Partners are acting as co-managers for the offering.
A registration statement on Form S-1 relating to these securities has been
filed with the Securities and Exchange Commission and declared effective. The
offering of these securities will be made only by means of a written prospectus
forming part of the effective registration statement relating to these
securities. Copies of the prospectus for this offering may be obtained, when
available, by contacting BofA Merrill Lynch, 222 Broadway, New York, NY 10038,
Attn: Prospectus Department, email: dg.prospectus_requests(at)baml.com, or Credit
Suisse Securities (USA) LLC, One Madison Avenue, New York, NY 10010; Tel:
1-800-221-1037; Attn: Credit Suisse Prospectus Department, email:
newyork.prospectus(at)credit-suisse.com, or RBC Capital Markets, LLC, 3 World
Financial Center, 200 Vesey Street, 8th Floor, New York, NY 10281-8098;
Attention: Equity Syndicate; Tel: 877-822-4089; Fax: 212-428-6260.
This press release shall not constitute an offer to sell or the solicitation of
an offer to buy, nor shall there be any sale of these securities in any state
or other jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the securities laws of
any such state or other jurisdiction.
CONTACT: Investors: Tran Nguyen, CFO
650-837-8535, IR(at)prothena.com
Media: Anita Kawatra
646-256-5116, anita.kawatra(at)prothena.com
News Source: NASDAQ OMX
03.10.2013 Dissemination of a Corporate News, transmitted by DGAP -
a company of EQS Group AG.
The issuer is solely responsible for the contentof this announcement.
DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
---------------------------------------------------------------------------
Language: English
Company: Prothena Corporation
Ireland
Phone:
Fax:
E-mail:
Internet:
ISIN: IE00B91XRN20
WKN:
End of Announcement DGAP News-Service
---------------------------------------------------------------------------
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: EquityStory
" alt="East West Petroleum Updates Progress on New Zealand Drilling Program
Datum: 03.10.2013 - 12:00 Uhr
Sprache: Deutsch
News-ID 302478
Anzahl Zeichen: 3157
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 269 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"DGAP-News: Prothena Announces Pricing of Public Offering of 5,910,000 Ordinary Shares"
steht unter der journalistisch-redaktionellen Verantwortung von
Prothena Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
